v3.23.1
INCOME TAX - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Income Tax Disclosure [Abstract]    
Capitalized R&D Expenses $ 5,199,721 $ 3,002,819
Other Deferred Items 145,935 121,152
Stock Compensation 484,205 50,650
Net Operating Loss - US 3,919,323 1,931,959
R&D Credits 3,293,572 1,068,451
Net deferred tax assets 13,042,756 6,175,031
Valuation Allowance (13,042,756) (6,175,031)
Net deferred tax assets (liabilities) $ 0 $ 0